150 related articles for article (PubMed ID: 2692018)
1. Absorption enhancement of intranasally administered insulin by sodium taurodihydrofusidate (STDHF) in rabbits and rats.
Deurloo MJ; Hermens WA; Romeyn SG; Verhoef JC; Merkus FW
Pharm Res; 1989 Oct; 6(10):853-6. PubMed ID: 2692018
[TBL] [Abstract][Full Text] [Related]
2. Absorption enhancement of rectally infused insulin by sodium tauro-24,25-dihydrofusidate (STDHF) in rats.
van Hoogdalem EJ; Heijligers-Feijen CD; Verhoef JC; de Boer AG; Breimer DD
Pharm Res; 1990 Feb; 7(2):180-3. PubMed ID: 2106676
[TBL] [Abstract][Full Text] [Related]
3. Effects of sodium taurodihydrofusidate on nasal absorption of insulin in sheep.
Longenecker JP; Moses AC; Flier JS; Silver RD; Carey MC; Dubovi EJ
J Pharm Sci; 1987 May; 76(5):351-5. PubMed ID: 3309255
[TBL] [Abstract][Full Text] [Related]
4. Tolerability and absorption enhancement of intranasally administered octreotide by sodium taurodihydrofusidate in healthy subjects.
Kissel T; Drewe J; Bantle S; Rummelt A; Beglinger C
Pharm Res; 1992 Jan; 9(1):52-7. PubMed ID: 1589410
[TBL] [Abstract][Full Text] [Related]
5. Intranasal bioavailability of insulin powder formulations: effect of permeation enhancer-to-protein ratio.
Lee WA; Narog BA; Patapoff TW; Wang YJ
J Pharm Sci; 1991 Aug; 80(8):725-9. PubMed ID: 1791529
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of bile acids and fusidate derivative as nasal absorption enhancers using an electrophysiological technique.
Hosoya K; Kubo H; Natsume H; Sugibayashi K; Morimoto Y
Biol Pharm Bull; 1999 Oct; 22(10):1089-93. PubMed ID: 10549861
[TBL] [Abstract][Full Text] [Related]
7. The effect of sodium tauro-24,25-dihydrofusidate on the nasal absorption of human growth hormone in three animal models.
Baldwin PA; Klingbeil CK; Grimm CJ; Longenecker JP
Pharm Res; 1990 May; 7(5):547-52. PubMed ID: 2367323
[TBL] [Abstract][Full Text] [Related]
8. Rectal absorption enhancement of cefoxitin and desglycinamide arginine vasopressin by sodium tauro-24,25-dihydrofusidate in conscious rats.
van Hoogdalem EJ; Heijligers-Feijen CD; Mathôt RA; Wackwitz AT; van Bree JB; Verhoef JC; de Boer AG; Breimer DD
J Pharmacol Exp Ther; 1989 Nov; 251(2):741-4. PubMed ID: 2810123
[TBL] [Abstract][Full Text] [Related]
9. Effects of absorption enhancers on human nasal tissue ciliary movement in vitro.
Hermens WA; Hooymans PM; Verhoef JC; Merkus FW
Pharm Res; 1990 Feb; 7(2):144-6. PubMed ID: 2408030
[TBL] [Abstract][Full Text] [Related]
10. Effect of sodium taurodihydrofusidate on nasal drug delivery: differences in its concentration and penetrant molecular weight.
Hosoya K; Kubo H; Akutsu T; Natsume H; Sugibayashi K; Morimoto Y
Arch Pharm Res; 1994 Apr; 17(2):57-9. PubMed ID: 10319131
[TBL] [Abstract][Full Text] [Related]
11. The adjuvant effect of bacitracin on nasal absorption of gonadorelin and buserelin in rats.
Raehs SC; Sandow J; Wirth K; Merkle HP
Pharm Res; 1988 Nov; 5(11):689-93. PubMed ID: 3150047
[TBL] [Abstract][Full Text] [Related]
12. Nasal insulin delivery with dimethyl-beta-cyclodextrin as an absorption enhancer in rabbits: powder more effective than liquid formulations.
Schipper NG; Romeijn SG; Verhoef JC; Merkus FW
Pharm Res; 1993 May; 10(5):682-6. PubMed ID: 8321831
[TBL] [Abstract][Full Text] [Related]
13. Absorption enhancing effect of cyclodextrins on intranasally administered insulin in rats.
Merkus FW; Verhoef JC; Romeijn SG; Schipper NG
Pharm Res; 1991 May; 8(5):588-92. PubMed ID: 1866372
[TBL] [Abstract][Full Text] [Related]
14. Confocal laser scanning microscopic visualization of the transport of dextrans after nasal administration to rats: effects of absorption enhancers.
Marttin E; Verhoef JC; Cullander C; Romeijn SG; Nagelkerke JF; Merkus FW
Pharm Res; 1997 May; 14(5):631-7. PubMed ID: 9165535
[TBL] [Abstract][Full Text] [Related]
15. Intranasal bioavailability of insulin from carbopol-based gel spray in rabbits.
Najafabadi AR; Moslemi P; Tajerzadeh H
Drug Deliv; 2004; 11(5):295-300. PubMed ID: 15742554
[TBL] [Abstract][Full Text] [Related]
16. Permeability enhancement in Caco-2 cell monolayers by sodium salicylate and sodium taurodihydrofusidate: assessment of effect-reversibility and imaging of transepithelial transport routes by confocal laser scanning microscopy.
Hurni MA; Noach AB; Blom-Roosemalen MC; de Boer AG; Nagelkerke JF; Breimer DD
J Pharmacol Exp Ther; 1993 Nov; 267(2):942-50. PubMed ID: 7504101
[TBL] [Abstract][Full Text] [Related]
17. Vaginal absorption of insulin in the rat: effect of penetration enhancers on insulin uptake and mucosal histology.
Richardson JL; Illum L; Thomas NW
Pharm Res; 1992 Jul; 9(7):878-83. PubMed ID: 1438000
[TBL] [Abstract][Full Text] [Related]
18. Nasal insulin delivery in the chitosan solution: in vitro and in vivo studies.
Yu S; Zhao Y; Wu F; Zhang X; Lü W; Zhang H; Zhang Q
Int J Pharm; 2004 Aug; 281(1-2):11-23. PubMed ID: 15288339
[TBL] [Abstract][Full Text] [Related]
19. Nasal delivery of insulin using bioadhesive chitosan gels.
Varshosaz J; Sadrai H; Heidari A
Drug Deliv; 2006; 13(1):31-8. PubMed ID: 16401591
[TBL] [Abstract][Full Text] [Related]
20. Nasal absorption and local tissue reaction of insulin nanocomplexes of trimethyl chitosan derivatives in rats.
Jintapattanakit A; Peungvicha P; Sailasuta A; Kissel T; Junyaprasert VB
J Pharm Pharmacol; 2010 May; 62(5):583-91. PubMed ID: 20609059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
